A groundbreaking study has unveiled how Staphylococcus aureus, a bacterium often found in humans, evolves and survives, ...

A new study reveals how Staphylococcus aureus can adapt and evolve to survive in and on its human carriers at a genetic level ...

The most detailed study to date on the mechanisms by which a common type of bacterium, Staphylococcus aureus, adapts to ...

Researchers have described how the bacterium Staphylococcus aureus genetically adapts to humans, including mutations that ...

cSSSI: Complicated skin and skin-structure infection; ESBL: Extended spectrum β lactamase; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus.

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome.The microbe poses a significant threat to public ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

Staphylococcus aureus (S. aureus). The FDA grants Fast Track designation to products under development that have the potential to treat or prevent serious conditions and address an unmet medical need.

Staphylococcus aureus is a foodborne bacterium that can be transmitted through air droplets or aerosol when coughing or sneezing. Some healthy humans carry this bacterium in the nose, in the back ...

“Studies of bacterial adaptation like this could also reveal mechanisms of immune evasion – how bacteria adapt to evade ...